Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sonal S Munsiff

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 14, 2024
Effects of Respiratory Isolation for Tuberculosis to Reduce Community-based Transmission: A Systematic ReviewRuvandhi R Nathavitharana, Abarna Pearl, Amanda Biewer, et al.
Emerging Infectious Diseases|May 18, 2006
Universal genotyping in tuberculosis control program, New York City, 2001-2003Carla M Clark, Cynthia R Driver, Sonal S Munsiff, et al.
Journal of Public Health Management and Practice : JPHMP|April 17, 2007
Human immunodeficiency virus counseling, testing, and referral of close contacts to patients with pulmonary tuberculosis: feasibility and costsJiehui Li, Suzanne M Marks, Cynthia R Driver, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 23, 2003
Effectiveness of isoniazid treatment for latent tuberculosis infection among human immunodeficiency virus (HIV)-infected and HIV-uninfected injection drug users in methadone programsJerod N Scholten, Cynthia R Driver, Sonal S Munsiff, et al.
American Journal of Respiratory and Critical Care Medicine|May 6, 2006
Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosisWilliam J Burman, Stefan Goldberg, John L Johnson, et al.
American Journal of Respiratory and Critical Care Medicine|July 22, 2025
Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice GuidelineJussi J Saukkonen, Raquel Duarte, Sonal S Munsiff, et al.
The Lancet. Infectious Diseases|January 29, 2022
Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre studySaranya Sridhar, Arnel Joaquin, Matthew I Bonaparte, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 14, 2024
Effects of Respiratory Isolation for Tuberculosis to Reduce Community-based Transmission: A Systematic ReviewRuvandhi R Nathavitharana, Abarna Pearl, Amanda Biewer, et al.
Emerging Infectious Diseases|May 18, 2006
Universal genotyping in tuberculosis control program, New York City, 2001-2003Carla M Clark, Cynthia R Driver, Sonal S Munsiff, et al.
Journal of Public Health Management and Practice : JPHMP|April 17, 2007
Human immunodeficiency virus counseling, testing, and referral of close contacts to patients with pulmonary tuberculosis: feasibility and costsJiehui Li, Suzanne M Marks, Cynthia R Driver, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 23, 2003
Effectiveness of isoniazid treatment for latent tuberculosis infection among human immunodeficiency virus (HIV)-infected and HIV-uninfected injection drug users in methadone programsJerod N Scholten, Cynthia R Driver, Sonal S Munsiff, et al.
American Journal of Respiratory and Critical Care Medicine|May 6, 2006
Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosisWilliam J Burman, Stefan Goldberg, John L Johnson, et al.
American Journal of Respiratory and Critical Care Medicine|July 22, 2025
Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice GuidelineJussi J Saukkonen, Raquel Duarte, Sonal S Munsiff, et al.
The Lancet. Infectious Diseases|January 29, 2022
Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre studySaranya Sridhar, Arnel Joaquin, Matthew I Bonaparte, et al.
Pageof 5